Navigation Links
Refocusing the boom in biomarker research

An article in the current edition of Chemical & Engineering News, ACS's weekly newsmagazine, describes the trials, tribulations, and triumphs of one of the hottest pursuits in modern biomedical science the search for "biomarkers" that could greatly improve the diagnosis of disease and efforts to monitor the effectiveness of treatment.

In the article, C&EN Senior Editor Celia Henry Arnaud explains that biomarkers are substances in human blood, urine, saliva and other body fluid that raise red flags for disease. Biomarkers may be present in abnormally high or low levels or in patterns that differ in health and disease. Some biomarker-based tests have made their way into every day medicine. One, for instance, is the familiar PSA test, long used to screen men for prostate cancer. Another, CA125, is used for ovarian and other forms of cancer.

Arnaud focuses on a boom in the search for new biomarkers that has been plagued with problems. Cancer biomarkers that appeared promising in research studies, for instance, turned out to be no better than CA125. The article suggests new approaches to improve biomarker discovery, including closer initial collaboration between research scientists and medical personnel who would use biomarkers in improving health care of patients.


Contact: Michael Bernstein
American Chemical Society

Page: 1

Related medicine news :

1. Researchers identify early biomarker for future atopy in asymptomatic children
2. Researchers find CDT biomarker ineffective for identifying unhealthy alcohol use
3. Study of biomarker development in mice provides a roadmap for a similar approach in humans
4. Tie Between Biomarkers, Disease Often Overstated, Scientists Say
5. VCU Massey Cancer Center finds new biomarker that predicts breast cancer relapse
6. BATTLE researchers identify new biomarkers for EGFR inhibition
7. Biomarker-driven science at the heart of new ACRIN-ECOG structure
8. Validation of salivary-biomarkers for Sjogrens syndrome detection in US population
9. Scientists ID possible biomarker to gauge Alzheimers prognosis, effect of therapies
10. Researchers discover possible biomarker and therapeutic target for melanoma
11. Study identifies therapeutic target for liver cancer and predictive biomarker of response
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/25/2016)... ... , ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter ... bar too high can result in disappointment, perhaps even self-loathing. However, those who set ... , Research from reveals that behind the tendency to set low ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... develops, markets and sells medical devices and wearable sleep ... a strategic cooperation agreement with Hongyuan Supply Chain Management ... on June 20, 2016, to develop Dehaier,s new Internet ... agreement, Dehaier will leverage Hongyuan Supply Chain,s sales platform ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: